An enzyme that fixes broken DNA sometimes destroys it instead, Stanford researchers find

November 26, 2014

Enzymes inside cells that normally repair damaged DNA sometimes wreck it instead, researchers at the Stanford University School of Medicine have found. The insight could lead to a better understanding of the causes of some types of cancer and neurodegenerative disease.

In a paper to be published online Nov. 27 in Molecular Cell, the researchers explain how the recently discovered mechanism of DNA damage occurs when genetic transcripts, composed of RNA, stick to the DNA instead of detaching from it.

Certain enzymes, called endonucleases, are attracted to DNA/RNA hybrids that form when gene transcription goes awry -- and they cut the DNA like scissors to damage it.

The researchers conducted the study with human cells in culture, using molecular biology techniques to turn off specific genes. This allowed them to induce cells to form the hybrids and to see what would happen when various enzymes were inhibited.

"What we found is when we get rid of these endonucleases, we don't see the damage," said Karlene Cimprich, PhD, professor of chemical and systems biology and the paper's senior author. "When those nucleases are present, they cut the DNA in the hybrid."

Both helpful and harmful

What's really interesting, said Cimprich, is these same enzymes are noted for fixing DNA damage. "They take part in the repair of DNA lesions from sunlight and certain chemicals, like those found in cigarette smoke," she said. The structures formed by the hybrid of RNA and DNA are similar to those formed in cells damaged by ultraviolet light.

"What we believe happens is that the repair machinery misrecognizes these structures and cuts them," she said. She and her colleagues have launched more experiments to figure out why this happens.

The study not only opens up new avenues for understanding DNA damage, it expands the role of the messenger RNA molecule. In the last decade, researchers have discovered many new roles for RNA, aside from its long-recognized role in providing instructions for building proteins.

"The messenger RNA is known to transmit the information and make the proteins," said Cimprich. "But we found that if it isn't removed properly it destroys the DNA that originally encoded it."

A study published by Cimprich and colleagues in Molecular Cell in 2009 alerted researchers to the importance of RNA in DNA damage. Their genomewide screen to identify factors that help fix DNA damage found hundreds of different molecules, some of which the researchers expected. But most of the molecules were surprises. And most interacted in some way with RNA, which pointed to RNA as a culprit in causing DNA damage.

"When we thought about what would cause DNA damage in cells, we thought about problems with DNA replication and DNA repair," she said. "But now we're beginning to see that problems with RNA can also feed back to the DNA."

Understanding role of enzymes

Now the researchers are trying to understand why some of the enzymes that control transcription are causing DNA damage, with an eye to understanding the roots of some cancers. "A lot of oncogenes are transcription factors. We're looking at whether those cause genome instability by making hybrids like those we've seen. Is this a different route to DNA damage and cancer?" Cimprich said.

"Recent work has also implicated these hybrids in neurodegenerative diseases, including Fragile X syndrome, Friedreich's ataxia and amyotrophic lateral sclerosis type 4," said Julie Sollier, PhD, the lead author of the paper and a postdoctoral researcher. "We would like to explore the potential role of the endonucleases we identified in these diseases as well."
Other Stanford co-authors are graduate student Caroline Townsend Stork and former graduate student Renee Paulsen, PhD. Researchers at the University of Seville in Spain also contributed to the paper.

The research was supported by the Spanish Ministry of Economy and Competitiveness, the European Union and the National Institutes of Health (grant GM100489).

Information about Stanford's Department of Chemical and Systems Biology, which also supported this work, is available at

The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit The medical school is part of Stanford Medicine, which includes Stanford Health Care and Lucile Packard Children's Hospital Stanford. For information about all three, please visit

Print media contact: Rosanne Spector at (650) 725-5374 (

Broadcast media contact: Margarita Gallardo at (650) 723-7897 (

Stanford University Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to